These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 29321323)

  • 1. HIV-1 Vif's Capacity To Manipulate the Cell Cycle Is Species Specific.
    Evans EL; Becker JT; Fricke SL; Patel K; Sherer NM
    J Virol; 2018 Apr; 92(7):. PubMed ID: 29321323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional and Structural Insights into a Vif/PPP2R5 Complex Elucidated Using Patient HIV-1 Isolates and Computational Modeling.
    Salamango DJ; McCann JL; Demir Ö; Becker JT; Wang J; Lingappa JR; Temiz NA; Brown WL; Amaro RE; Harris RS
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32847850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Critical role of PP2A-B56 family protein degradation in HIV-1 Vif mediated G2 cell cycle arrest.
    Nagata K; Shindo K; Matsui Y; Shirakawa K; Takaori-Kondo A
    Biochem Biophys Res Commun; 2020 Jun; 527(1):257-263. PubMed ID: 32446377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vif-CBFβ interaction is essential for Vif-induced cell cycle arrest.
    Du J; Rui Y; Zheng W; Li P; Kang J; Zhao K; Sun T; Yu XF
    Biochem Biophys Res Commun; 2019 Apr; 511(4):910-915. PubMed ID: 30851937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evolutionarily conserved pressure for the existence of distinct G2/M cell cycle arrest and A3H inactivation functions in HIV-1 Vif.
    Zhao K; Du J; Rui Y; Zheng W; Kang J; Hou J; Wang K; Zhang W; Simon VA; Yu XF
    Cell Cycle; 2015; 14(6):838-47. PubMed ID: 25590520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperativity among Rev-associated nuclear export signals regulates HIV-1 gene expression and is a determinant of virus species tropism.
    Aligeti M; Behrens RT; Pocock GM; Schindelin J; Dietz C; Eliceiri KW; Swanson CM; Malim MH; Ahlquist P; Sherer NM
    J Virol; 2014 Dec; 88(24):14207-21. PubMed ID: 25275125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term passage of Vif-null HIV-1 in CD4
    Miyagi E; Kao S; Fumitaka M; Buckler-White A; Plishka R; Strebel K
    Virology; 2017 Apr; 504():1-11. PubMed ID: 28131088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin F/FBXO1 Interacts with HIV-1 Viral Infectivity Factor (Vif) and Restricts Progeny Virion Infectivity by Ubiquitination and Proteasomal Degradation of Vif Protein through SCF
    Augustine T; Chaudhary P; Gupta K; Islam S; Ghosh P; Santra MK; Mitra D
    J Biol Chem; 2017 Mar; 292(13):5349-5363. PubMed ID: 28184007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HIV-1 Vif protein mediates degradation of Vpr and reduces Vpr-induced cell cycle arrest.
    Wang J; Shackelford JM; Selliah N; Shivers DK; O'Neill E; Garcia JV; Muthumani K; Weiner D; Yu XF; Gabuzda D; Finkel TH
    DNA Cell Biol; 2008 May; 27(5):267-77. PubMed ID: 18462066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of dominant negative human immunodeficiency virus type 1 Vif mutants that interfere with the functional inactivation of APOBEC3G by virus-encoded Vif.
    Walker RC; Khan MA; Kao S; Goila-Gaur R; Miyagi E; Strebel K
    J Virol; 2010 May; 84(10):5201-11. PubMed ID: 20219919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-APOBEC3G activity of HIV-1 Vif protein is attenuated in elite controllers.
    Kikuchi T; Iwabu Y; Tada T; Kawana-Tachikawa A; Koga M; Hosoya N; Nomura S; Brumme ZL; Jessen H; Pereyra F; Trocha A; Walker BD; Iwamoto A; Tokunaga K; Miura T
    J Virol; 2015 May; 89(9):4992-5001. PubMed ID: 25717111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 Vif protein binds the editing enzyme APOBEC3G and induces its degradation.
    Marin M; Rose KM; Kozak SL; Kabat D
    Nat Med; 2003 Nov; 9(11):1398-403. PubMed ID: 14528301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of the HIV-1 Vif and Human APOBEC3G Protein Interface.
    Letko M; Booiman T; Kootstra N; Simon V; Ooms M
    Cell Rep; 2015 Dec; 13(9):1789-99. PubMed ID: 26628364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Progress in the study of HIV-1 Vif and related inhibitors].
    Li ZY; Zhan P; Liu XY
    Yao Xue Xue Bao; 2010 Jun; 45(6):684-93. PubMed ID: 20939174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An analog of camptothecin inactive against Topoisomerase I is broadly neutralizing of HIV-1 through inhibition of Vif-dependent APOBEC3G degradation.
    Bennett RP; Stewart RA; Hogan PA; Ptak RG; Mankowski MK; Hartman TL; Buckheit RW; Snyder BA; Salter JD; Morales GA; Smith HC
    Antiviral Res; 2016 Dec; 136():51-59. PubMed ID: 27825797
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simian Immunodeficiency Virus Vif and Human APOBEC3B Interactions Resemble Those between HIV-1 Vif and Human APOBEC3G.
    Wang J; Shaban NM; Land AM; Brown WL; Harris RS
    J Virol; 2018 Jun; 92(12):. PubMed ID: 29618650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. APOBEC3G and APOBEC3F Act in Concert To Extinguish HIV-1 Replication.
    Krisko JF; Begum N; Baker CE; Foster JL; Garcia JV
    J Virol; 2016 May; 90(9):4681-4695. PubMed ID: 26912618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Core Binding Factor β Protects HIV, Type 1 Accessory Protein Viral Infectivity Factor from MDM2-mediated Degradation.
    Matsui Y; Shindo K; Nagata K; Yoshinaga N; Shirakawa K; Kobayashi M; Takaori-Kondo A
    J Biol Chem; 2016 Nov; 291(48):24892-24899. PubMed ID: 27758855
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploiting a rodent cell block for intrinsic resistance to HIV-1 gene expression in human T cells.
    Behrens RT; Rajashekar JK; Bruce JW; Evans EL; Hansen AM; Salazar-Quiroz N; Simons LM; Ahlquist P; Hultquist JF; Kumar P; Sherer NM
    mBio; 2023 Oct; 14(5):e0042023. PubMed ID: 37676006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Host AKT-mediated phosphorylation of HIV-1 accessory protein Vif potentiates infectivity via enhanced degradation of the restriction factor APOBEC3G.
    Raja R; Wang C; Mishra R; Das A; Ali A; Banerjea AC
    J Biol Chem; 2022 Apr; 298(4):101805. PubMed ID: 35259395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.